Press Releases
Published: October 18, 2021

Propeller Health research shows digital health programs help improve outcomes for vulnerable and underserved populations with chronic respiratory conditions

News Announcement at HLTH 2021, Boston MA, October 18, 2021

MADISON, Wisconsin, October 18, 2021 – Propeller Health, a leader in digital health and therapeutics for asthma and chronic obstructive pulmonary disease (COPD), revealed two recent studies that showed that digital health interventions alongside appropriate care resources and tools can expand access and improve outcomes for elderly and underserved populations. Propeller’s digital health platform includes Bluetooth® connected inhaler sensors that chime medication reminders and record inhaler medication use, paired with a smartphone app that provides education and feedback to support self-management.

In a study1 conducted in partnership with Desert Oasis Healthcare, Propeller evaluated the effect of digital health intervention on healthcare resource utilization and medication use in patients with COPD. 56 patients with COPD, average age 75, were enrolled by their clinical pharmacists, who received alerts through Propeller’s clinician portal whenever patients showed low controller medication adherence or high rescue inhaler use.

After six months, the study showed a 48% reduction in healthcare resource utilization and 61.5% controller medication adherence among enrolled patients. The reduction in utilization included a 24% decrease in COPD-related oral corticosteroid prescriptions and a 45% decline in COPD-related emergency department visits and hospitalizations.

In another study2, Propeller teamed up with the Detroit Health Department, Detroit Public Schools Community District, Wayne State University and Kids’ Health Connections, a nonprofit that provides health education and services to Medicaid-enrolled and other economically disadvantaged children, to deliver a digital program to help children aged 6-13 years better manage their asthma between doctor appointments. Caregivers and providers received regular access to the data to monitor trends in the children’s respiratory health.

Over a three month period, average rescue inhaler use decreased 63% among the 51 children enrolled, suggesting they experienced fewer asthma-related symptoms. Average duration without rescue inhaler use increased by nearly three days per month, further suggesting that the children enjoyed more days without asthma impact. Overall, 76% of the participants increased their number of days without rescue inhaler use.

“These results demonstrate the potential of digital health tools backed by coaching and clinical support in improving healthcare access and health equity for people who need it the most,” said Susa Monacelli, Propeller Health general manager. “We are committed to scaling our programs through remote therapeutic monitoring and value-based care arrangements to help even more people benefit from digital health interventions and enjoy better quality of life.”

1Presented at the European Respiratory Society International Congress 2021
2Barrett et al. (2021).

About Propeller Health

At Propeller Health, our mission is to empower every person living with a chronic respiratory disease to take control of their health so they can live a better life. As a leader in digital health and therapeutics for asthma and COPD, we work to improve clinical outcomes, healthcare costs, and quality of life by supporting patients in managing their condition with their healthcare provider.

Propeller’s platform includes FDA-cleared medical devices, consumer apps and access to clinical data for provider monitoring throughout the care journey, to create value to all stakeholders. We enable a personalized digital experience with a human touch used by patients, caregivers, providers, payers, pharmaceutical companies and other healthcare organizations across the US, Europe and Asia.

Propeller Health is a wholly owned subsidiary of ResMed. For more information, visit www.propellerhealth.com.

Media Contact:
VJ Bala
SVP Marketing, Propeller Health
vj.bala@propellerhealth.com
703-597-3433

You Might Also Like

Propeller Health Named a Winner of Fierce Healthcare Innovation Awards 2022

Propeller Health’s precision digital health platform wins the Clinical Information Management category of the Fierce Healthcare Innovation Awards 2022. The platform enables physicians and care teams to proactively identify at-risk patients in between routine visits and provide more timely clinical interventions.

MADISON, WI, November 15, 2022 – Propeller Health, a leader in precision digital health, today announces its platform for chronic condition management is a Fierce Healthcare Innovation Awards 2022 winner. The program showcases outstanding innovation that is driving improvements and transforming the industry. The Propeller Digital Health Platform for Chronic Condition Management (The Propeller Platform”) enables proactive clinical care by collecting objective patient data and displaying resulting insights directly within a provider’s native workflow. 

At Propeller, data itself is only the beginning – activating it is what powers patient care,” said Susa Monacelli, Propeller Health General Manager. By surfacing the data within clinicians' existing workflow through EHR integrations, we enable their treatment decisions and help identify at-risk patients. Patient self-management coupled with proactive clinician intervention helps improve clinical outcomes and, in turn, economic value for health systems, payers, and patients. Our focus is to do this across connected medications and therapies to change healthcare at scale.”

Propeller Health accelerates push towards value-based care with new digital health solutions for patients, providers and health systems

Announces integrations with multiple leading Electronic Health Record (EHR) systems, introduces a new solution to enable Remote Therapeutic Monitoring (RTM) by healthcare providers, and launches digital platform updates to enable respiratory care at home, in-clinic, and on-the-go.

MIAMI, March 7, 2022 – Propeller Health, a leader in digital health for asthma and chronic obstructive pulmonary disease (COPD), today announced three exciting updates and new solutions to bring its clinically proven, FDA-cleared platform to more patients, providers and health systems.

Integrations expand the reach of Propeller’s digital platform to more health systems
Dignity Health and Propeller Health Bring Asthma and COPD Digital Inhaler Data into EHR
Integrating data from the Propeller platform into Dignity Health’s EHR improves clinical and operational efficiencies and provides physicians with real-time insights to improve patient treatment decisions. SAN FRANCISCO – October 5, 2021 – Dignity Health, which is part of 21-state health system CommonSpirit Health, and Propeller Health, a leader in digital health and therapeutics for asthma and chronic obstructive pulmonary disease (COPD), announced today that they have integrated Propeller’s platform into Dignity Health’s electronic health record (EHR) system. This integration has been fully implemented in seven communities served by Dignity Health physicians and clinics in Arizona and California. With the EHR integration, Dignity Health and Propeller could potentially scale the tool to hundreds of physicians who care for thousands of patients with an eligible diagnosis. Now, the Propeller solution can be ordered and managed through the EHR like any other medication or treatment. Enrollment is streamlined for providers and staff as they don’t have to leave their clinical workflow: it now takes two minutes to enroll a patient, which is a 75-80% reduction in time.